The pharmacokinetics and toxicity of once-daily tobramycin therapy in children with cystic fibrosis

Journal of Antimicrobial Chemotherapy

Volumn 42, Issue 1, 1998, Pages 103-106

  Bragonier, R ^a   Brown, N M ^b  

^a BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; TOBRAMYCIN;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CYSTIC FIBROSIS; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; OTOTOXICITY; PSEUDOMONAS AERUGINOSA; RESPIRATORY TRACT INFECTION; SCHOOL CHILD;

ADOLESCENT; ANTI-BACTERIAL AGENTS; CHILD; CYSTIC FIBROSIS; FEMALE; HALF-LIFE; HUMANS; KIDNEY; MALE; METABOLIC CLEARANCE RATE; TOBRAMYCIN;

EID: 0031849277     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/42.1.103     Document Type: Article

References (9)

1. Wood, P. J., Ioannides-Demos, L. L., Li, S. C., Williams, T. J., Hickey, B., Spicer, W. J. et al. (1996). Minimisation of aminoglycoside toxicity in patients with cystic fibrosis. Thorax 51, 369-73.
2. loannides-Demos, L. L., Li, S. C., Bastone, E. B., Spelman, D. W., Hooper, R. E., Cousins, V. C. et al. (1994). Absence of toxicity in patients with malignant otitis externa following long-term treatment with high dosage tobramycin. Journal of Antimicrobial Chemotherapy 34, 267-74.
3. Levy, J., Smith, A. L., Koup, J. R., Williams-Warren, J. & Ramsey, B. (1984). Disposition of tobramycin in patients with cystic fibrosis: a prospective controlled study. Journal of Pediatrics 105, 117-24.
4. Powell, S. H., Thompson, W. L., Luthe, M. A., Stern, R. C., Grossniklaus, D. A., Bloxham, D. D. et al. (1983). Once-daily vs. continuous aminoglycoside dosing: efficacy and toxicity in animal and clinical studies of gentamicin, netilmicin and tobramycin. Journal of Infectious Diseases 147, 918-32.
5. Guglielmo, B. J., Quan, L. A. & Stulbarg, M. S. (1996). Pharmacokinetics of once-daily versus thrice daily tobramycin in cystic fibrosis patients. Journal of Antimicrobial Chemotherapy 37, 1040-2.
6. Smith, D. L., Stableforth, D. E. & Geddes, A. M. (1994). Evaluation of a once-daily netilmicin regimen in the treatment of cystic fibrosis. Journal of Antimicrobial Chemotherapy 33, 191-3.
7. Canis, F., Husson, M. O., Turck, D., Vie, P., Launay, V., Ategbo, S. et al. (1997). Pharmacokinetics and bronchial diffusion of single daily dose amikacin in cystic fibrosis patients. Journal of Antimicrobial Chemotherapy 39, 431-3.
8. Begg, E. J., Barclay, M. L. & Duffull, S. B. (1995). A suggested approach to once-daily aminoglycoside dosing. British Journal of Clinical Pharmacology 39, 605-9.
9. Wilson, P. & Ramsden, R. T. (1977). Immediate effects of tobramycin on human cochlea and correlation with serum tobramycin levels. British Medical Journal i, 259-61.